G
GSK
GSK PLC
51.08
+0.86+1.71%Pre Market: 51.08 0.00 0.00%04:00 09/22 EDT
OPEN/PREV CLOSE46.73/47.03
TODAY RANGE46.33-46.89
VOL2.12K
MARKET CAP94.16B
52 WEEK RANGE41.38-60.12
AVG VOL (3M)3.68M
% TURNOVER0.17%
TURNOVER--
P/E (TTM)14.88
% RANGE1.15%
EPS(TTM)3.129
P/E(FORWARD)14.09
P/B4.055
BVPS11.48
DIVIDEND1.817
P/S2.158
BETA--
DIV YIELD3.90%
FREE FLOAT MKT CAP94.10B
SHARES OUTSTANDING2.02B
NEXT EARNINGS--
FREE FLOAT2.02B
LOT SIZE1
EX-DATE08/14/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2h ago
Measles outbreak: New York declares disaster emergency as cases rise
Seeking Alpha·2d ago
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
Seeking Alpha·3d ago
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
TipRanks·4d ago
GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan
Seeking Alpha·5d ago
FDA launches recruitment drive to add members to advisory panels
Seeking Alpha·5d ago
Pharmaceutical industry lobbying group names new CEO, Eric Cantor
Seeking Alpha·5d ago
Wave to receive $12M milestone as GSK picks liver candidate
Seeking Alpha·6d ago
CDC data now show two measles deaths for 2026; Pennsylvania records four
TipRanks·09/29 09:56
Deutsche Bank Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
TipRanks·09/29 09:25
Barclays Sticks to Its Sell Rating for GlaxoSmithKline (GSK)
TipRanks·09/29 09:15
Jefferies Remains a Buy on GlaxoSmithKline (GSK)
TipRanks·09/28 17:25
Brookline says BARDA contract a major positive for Scynexis’ SCY-247 program
Seeking Alpha·09/24 19:36
FDA commissioner nominee Overton rebuffs questions about Trump medical claims
Same Industry
Name/Symbol
Change%
Price